| Name | Title | Contact Details |
|---|
Natera Inc. is a genetic testing company that specializes in analyzing tiny quantities of DNA for reproductive health. Natera operates a CLIA-certified laboratory in San Carlos, Calif., providing a host of preconception and prenatal genetic testing services. Test offerings include pre-implantation genetic diagnosis to identify chromosomal anomalies or inherited genetic conditions in embryos generated during an IVF cycle; products-of-conception testing following miscarriage to analyze fetal chromosomes and understand the cause of the pregnancy loss; non-invasive prenatal testing to determine paternity; carrier screening to detect whether parents carry genetic variations that may result in disease in the child; and Panorama, a safe, simple test for pregnant women that identifies the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Natera's PreNATUS clinical trial for non-invasive screening of fetal chromosomal anomalies is funded by the NIH and is being conducted by the leaders in maternal-fetal medicine in the United States. These tests were developed by Natera, a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). In August, Natera was selected by the World Economic Forum as a Technology Pioneer for innovations in prenatal care. For more information, visit www.natera.com.
Diagnostic Outpatient Center is a St Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Delta Imaging Systems Inc is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Emerge Clinical Decision Solutions, a leader in the cardiology technology world, engineers software developed by leading cardiologists to help medical providers and administrators improve care. The software leverages a patented algorithm to analyze more than 8,000 unique data points in seconds and help alert doctors of any missed information, suggest specific tests and outline appropriate care paths. By helping doctors pinpoint conditions that are traditionally more difficult to diagnose, Emerge is helping patients receive the right care at the right time before costly, stressful emergency visits become necessary. The software has been proven to increase identification of certain cardiac diseases by as much as 300 percent.
Central Blood Bank is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.